Multidrug resistance protein 1 (mrp1, abcc1), a "multitasking" atp-binding cassette (abc,) transporter

Journal of Biological Chemistry

Volumn 289, Issue 45, 2014, Pages 30880-30888

  Cole, Susan P C ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ATP-BINDING CASSETTE; MULTIDRUG RESISTANCE;

ADENOSINE TRIPHOSPHATE; GLUTATHIONE; LEUKOTRIENE C4; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 1; ANION; ANTIOXIDANT; ESTROGEN; LIPID; LYSOPHOSPHOLIPID; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1; OXYGEN; XENOBIOTIC AGENT;

AGE RELATED MACULAR DEGENERATION; CARDIOVASCULAR DISEASE; HUMAN; HYDROLYSIS; IN VITRO STUDY; MALIGNANT NEOPLASTIC DISEASE; NEUROLOGIC DISEASE; NONHUMAN; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN TRANSPORT; REVIEW; TUMOR GROWTH; ANIMAL; CHEMISTRY; INFLAMMATION; METABOLISM; MOUSE; OXIDATIVE STRESS; PHYSIOLOGY; SIGNAL TRANSDUCTION; TRANSPORT AT THE CELLULAR LEVEL; TUMOR CELL LINE;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANIONS; ANTIOXIDANTS; BIOLOGICAL TRANSPORT; CELL LINE, TUMOR; ESTROGENS; GLUTATHIONE; HUMANS; INFLAMMATION; LEUKOTRIENE C4; LIPIDS; LYSOPHOSPHOLIPIDS; MICE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; OXIDATIVE STRESS; OXYGEN; SIGNAL TRANSDUCTION; XENOBIOTICS;

EID: 84910027197     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.R114.609248     Document Type: Review

References (103)

1. Higgins, C. F. (1992) ABC transporters: from microorganisms to man. Annu. Rev. Cell Biol. 8, 67-113
2. Slot, A. J., Molinski, S. V., and Cole, S. P. C. (2011) Mammalian multidrug resistance proteins (MRPs). Essays Biochem. 50, 179-207
3. Cole, S. P. C., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M. V., and Deeley, R. G. (1992) Overexpression of a transporter gene in a multidrug resistant human lung cancer cell line. Science 258, 1650-1654
4. Cole, S. P. C. (2014) Targeting the multidrug resistance protein (MRP1, ABCC1): past, present and future. Annu. Rev. Pharmacol. Toxicol. 54, 95-117
5. Szczypka, M. S., Wemmie, J. A., Moye-Rowley, W. S., and Thiele, D. J. (1994) A yeast metal resistance protein similar to human cystic fibrosis transmembrane conductance regulator (CFTR) and multidrug resis-tance- associated protein. J. Biol. Chem. 269, 22853-22857
6. Hamdoun, A. M., Cherr, G. N., Roepke, T. A., and Epel, D. (2004) Activation of multidrug efflux transporter activity at fertilization in sea urchin embryos (Strongylocentrotus purpuratus). Dev. Biol. 276, 452-462
7. Klein, M., Burla, B., and Martinoia, E. (2006) The multidrug resistanceassociated protein (MRP/ABCC) subfamily of ATP-binding cassette transporters in plants. FEBS Lett. 580, 1112-1122
8. Deeley, R. G., Westlake, C., and Cole, S. P. C. (2006) Transmembrane transport of endo- and xenobiotics by membrane ATP-binding cassette multidrug resistance proteins. Physiol. Rev. 86, 849-899
9. Li, J., Li, Z. N., Yu, L. C., Bao, Q. L., Wu, J. R., Shi, S. B., and Li, X. Q. (2010) Association of expression of MRP1, BCRP, LRP and ERCC1 with outcome of patients with locally advanced non-small cell lung cancer who received neoadjuvant chemotherapy. Lung Cancer 69, 116-122
10. Bagnoli, M., Beretta, G. L., Gatti, L., Pilotti, S., Alberti, P., Tarantino, E., Barbareschi, M., Canevari, S., Mezzanzanica, D., and Perego, P. (2013) Clinicopathological impact of ABCC1/MRP1 and ABCC4/MRP4 in epithelial ovarian carcinoma. Biomed. Res. Int. 2013, 143202
11. Hlaváč, V., Brynychová, V., Václavíková, R., Ehrlichová, M., Vrána, D., Pecha, V., Koževnikovová, R., Trnková, M., Gatěk, J., Kopperová, D., Gut, I., and Souček, P. (2013) The expression profile of ATP-binding cassette transporter genes in breast carcinoma. Pharmacogenomics 14, 515-529
12. Haber, M., Smith, J., Bordow, S. B., Flemming, C., Cohn, S. L., London, W. B., Marshall, G. M., and Norris, M. D. (2006) Association of high level MRP1 expression with poor clinical outcome in a large prospective study of primary neuroblastoma. J. Clin. Oncol. 24, 1546-1553
13. Lee, S. H., Lee, M.-S., Lee, J. H., Kim, S. W., Kang, R.-H., Choi, M.-J., Park, S. J., Kim, S. J., Lee, J. M., Cole, S. P. C., and Lee, M. G. (2010) MRP1 polymorphisms associated with citalopram response in patients with major depression. J. Clin. Psychopharmacol. 30, 116-125
14. Knauer, M. J., Urquhart, B. L., Meyer zu Schwabedissen, H. E., Schwarz, U. I., Lemke, C. J., Leake, B. F., Kim, R. B., and Tirona, R. G. (2010) Human skeletal muscle drug transporters determine local exposure and toxicity of statins. Circ. Res. 106, 297-306
15. Su, W., and Pasternak, G. W. (2013) The role of multidrug resistanceassociated protein in the blood-brain barrier and opioid analgesia. Synapse 67, 609-619
16. Leslie, E. M., Deeley, R. G., and Cole, S. P. C. (2005) Multidrug resistance proteins in toxicology: role of P-glycoprotein, MRP1, MRP2 and BCRP (ABCG2) in tissue defense. Toxicol. Appl. Pharmacol. 204, 216-237
17. Wijnholds, J., Evers, R., van Leusden, M. R., Mol, C. A. A. M., Zaman, G. J. R., Mayer, U., Beijnen, J. H., van der Valk, M., Krimpenfort, P., and Borst, P. (1997) Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein. Nat. Med. 3, 1275-1279
18. Wijnholds, J., deLange, E. C. M., Scheffer, G. L., van den Berg, D.-J., Mol, C. A. A. M., van der Valk, M., Schinkel, A. H., Scheper, R. J., Breimer, D. D., and Borst, P. (2000) Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier. J. Clin. Invest. 105, 279-285
19. Wojnowski, L., Kulle, B., Schirmer, M., Schlüter, G., Schmidt, A., Rosenberger, A., Vonhof, S., Bickeböller, H., Toliat, M. R., Suk, E. K., Tzvetkov, M., Kruger, A., Seifert, S., Kloess, M., Hahn, H., Loeffler, M., Nürnberg, P., Pfreundschuh, M., Trümper, L., Brockmöller, J., and Hasenfuss, G. (2005) NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity. Circulation 112, 3754-3762
20. Semsei, A. F., Erdelyi, D. J., Ungvari, I., Csagoly, E., Hegyi, M. Z., Kiszel, P. S., Lautner-Csorba, O., Szabolcs, J., Masat, P., Fekete, G., Falus, A., Szalai, C., and Kovacs, G. T. (2012) ABCC1 polymorphisms in anthracy-cline- induced cardiotoxicity in childhood acute lymphoblastic leukaemia. Cell Biol. Int. 36, 79-86
21. Visscher, H., Ross, C. J., Rassekh, S. R., Barhdadi, A., Dubé, M. P., Al- Saloos, H., Sandor, G. S., Caron, H. N., van Dalen, E. C., Kremer, L. C., van der Pal, H. J., Brown, A. M., Rogers, P. C., Phillips, M. S., Rieder, M. J., Carleton, B. C., Hayden, M. R., and Canadian Pharmacogenomics Network for Drug Safety Consortium (2012) Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children. J. Clin. Oncol. 30, 1422-1428
22. Blokzijl, H., van Steenpaal, A., Vander Borght, S., Bok, L. I. H., Libbrecht, L., Tamminga, M., Geuken, M., Roskams, T. A. D., Dijkstra, G., Moshage, H., Jansen, P. L. M., and Faber, K. N. (2008) Up-regulation and cytoprotective role of epithelial multidrug resistance-associated protein 1 in inflammatory bowel disease. J. Biol. Chem. 283, 35630-35637
23. Yoshioka, M., Sagara, H., Takahashi, F., Harada, N., Nishio, K., Mori, A., Ushio, H., Shimizu, K., Okada, T., Ota, M., Ito, Y. M., Nagashima, O., Atsuta, R., Suzuki, T., Fukuda, T., Fukuchi, Y., and Takahashi, K. (2009) Role of multidrug resistance-associated protein 1 in the pathogenesis of allergic airway inflammation. Am. J. Physiol. Lung Cell Mol. Physiol. 296 L30-36 Role of multidrug resistance-associated protein 1 in the pathogenesis of allergic airway inflammation. Am. J. Physiol. Lung Cell Mol. Physiol. 296, L30-36
24. Park, H. A., Kubicki, N., Gnyawali, S., Chan, Y. C., Roy, S., Khanna, S., and Sen, C. K. (2011) Natural vitamin E α-tocotrienol protects against ischemic stroke by induction of multidrug resistance-associated protein 1. Stroke 42, 2308-2314
25. 4 action reduces oxidative stress and apoptosis in cardiomyocytes and impedes remodeling after myocardial injury. J. Mol. Cell Cardiol. 50, 570-577
26. Sreekumar, P. G., Spee, C., Ryan, S. J., Cole, S. P. C., Kannan, R., and Hinton, D. R. (2012) Mechanism of RPE cell death in α-crystallin deficient mice: a novel and critical role for MRP1-mediated GSH efflux. PLoS One 7, e33420
27. Krohn, M., Lange, C., Hofrichter, J., Scheffler, K., Stenzel, J., Steffen, J., Schumacher, T., Brüning, T., Plath, A. S., Alfen, F., Schmidt, A., Winter, F., Rateitschak, K., Wree, A., Gsponer, J., Walker, L. C., and Pahnke, J. (2011) Cerebral amyloid- proteostasis is regulated by the membrane transport protein ABCC1 in mice. J. Clin. Invest. 121, 3924-3931
28. Fletcher, J. I., Haber, M., Henderson, M. J., and Norris, M. D. (2010) ABC transporters in cancer: more than just drug efflux pumps. Nat. Rev. Cancer 10, 147-156
29. Cole, S. P. C., and Deeley, R. G. (2006) Transport of glutathione and glutathione conjugates by MRP1. Trends Pharmacol. Sci. 27, 438-446
30. Ballatori, N., Krance, S. M., Marchan, R., and Hammond, C. L. (2009) Plasma membrane glutathione transporters and their roles in cell physiology and pathophysiology. Mol. Aspects Med. 30, 13-28
31. Bellarosa, C., Bortolussi, G., and Tiribelli, C. (2009) The role of ABC transporters in protecting cells from bilirubin toxicity. Curr. Pharm. Des. 15, 2884-2892
32. Bakos, E., Evers, R., Calenda, G., Tusnády, G. E., Szakács, G., Váradi, A., and Sarkadi, B. (2000) Characterization of the amino-terminal regions in the human multidrug resistance protein (MRP1). J. Cell Sci. 113, 4451-4461
33. 2terminal membrane spanning domain of multidrug resistance protein1 in protein processing and plasma membrane targeting. Mol. Biol. Cell 16, 2483-2492
34. Rosenberg, M. F., Oleschuk, C. J., Wu, P., Mao, Q., Deeley, R. G., Cole, S. P. C., and Ford, R. C. (2010) Structure of a human multidrug transporter in an inward-facing conformation. J. Struct. Biol. 170, 540-547
35. Jones, P. M., and George, A. M. (2014) A reciprocating twin-channel model for ABC transporters. Q. Rev. Biophys. 47, 189-220
36. Hollenstein, K., Dawson R. J., and Locher, K. P. (2007) Structure and mechanism of ABC transporter proteins. Curr. Opin. Struct. Biol. 17, 412-418
37. Chang, X. B. (2010) Molecular mechanisms of ATP-dependent solute transport by multidrug resistance-associated protein 1. Methods Mol. Biol. 596, 223-249
38. Ernst, R., Kueppers, P., Klein, C. M., Schwarzmueller, T., Kuchler, K., and Schmitt, L. (2008) A mutation of the H-loop selectively affects rhodamine transport by the yeast multidrug ABC transporter Pdr5. Proc. Natl. Acad. Sci. U.S.A. 105, 5069-5074
39. Koike, K., Conseil, G., Leslie, E. M., Deeley, R. G., and Cole, S. P. C. (2004) Identification of proline residues in the core cytoplasmic and transmembrane regions of multidrug resistance protein 1 (MRP1/ABCC1) important for transport function, substrate specificity, and nucleotide interactions. J. Biol. Chem. 279, 12325-12336
40. Deeley, R. G., and Cole, S. P. C. (2006) Substrate recognition and transport by multidrug resistance protein 1 (ABCC1). FEBS Lett. 580, 1103-1111
41. Seelig, A., Blatter, X. L., and Wohnsland, F. (2000) Substrate recognition by P-glycoprotein and the multidrug resistance-associated protein MRP1: a comparison. Int. J. Clin. Pharmacol. Ther. 38, 111-121
42. Ito, K., Olsen, S. L., Qiu, W., Deeley, R. G., and Cole, S. P. C. (2001) Mutation of a single conserved tryptophan in multidrug resistance protein 1 (MRP1/ABCC1) results in loss of drug resistance and selective loss of organic anion transport. J. Biol. Chem. 276, 15616-15624
43. Haimeur, A., Deeley, R. G., and Cole, S. P. C. (2002) Charged amino acids in the sixth transmembrane helix of multidrug resistance protein 1 (MRP1/ABCC1) are critical determinants of transport activity. J. Biol. Chem. 277, 41326-41333
44. Karwatsky, J., Daoud, R., Cai, J., Gros, P., and Georges, E. (2003) Binding of a photoaffinity analogue of glutathione to MRP1 (ABCC1) within two cytoplasmic regions (L0 and L1) as well as transmembrane domains 10-11 and 16-17. Biochemistry 42, 3286-3294
45. Zhang, D. W., Nunoya, K., Vasa, M., Gu, H. M., Cole, S. P. C., and Deeley, R. G. (2006) Mutational analysis of polar amino acid residues within predicted transmembrane helices 10 and 16 of multidrug resistance protein 1 (ABCC1): effect on substrate specificity. Drug Metab. Dispos. 34, 539-546
46. 1254 in the multispecific organic anion transporter, multidrug resistance protein 2 (MRP2) (ABCC2), alters substrate specificity and results in loss of methotrexate transport activity. J. Biol. Chem. 276, 38108-38114
47. Moreau, C., Gally, F., Jacquet-Bouix, H., and Vivaudou, M. (2005) The size of a single residue of the sulfonylurea receptor dictates the effectiveness of K ATP channel openers. Mol. Pharmacol. 67, 1026-1033
48. El-Sheikh, A. A., van den Heuvel, J. J., Krieger, E., Russel, F. G., and Koenderink, J. B. (2008) Functional role of arginine 375 in transmembrane helix 6 of multidrug resistance protein 4 (MRP4/ABCC4). Mol. Pharmacol. 74, 964-971
49. Crowley, E., O'Mara, M. L., Kerr, I. D., and Callaghan, R. (2010) Transmembrane helix 12 plays a pivotal role in coupling energy provision and drug binding in ABCB1. FEBS J. 277, 3974-3985
50. 4 binding sites. Mol. Pharmacol. 68, 1455-1465
51. Maeno, K., Nakajima, A., Conseil, G., Rothnie, A., Deeley, R. G., and Cole, S. P. C. (2009) Molecular basis for reduced estrone sulfate transport and altered modulator sensitivity of TM6 and TM17 mutants of MRP1 (ABCC1). Drug Metab. Dispos. 37, 1411-1420
52. Gottesman, M. M., and Ling, V. (2006) The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research. FEBS Lett. 580, 998-1009
53. DeGorter, M. K., Conseil, G., Deeley, R. G., Campbell, R. L., and Cole, S. P. C. (2008) Molecular modelling of the human multidrug resistance protein 1 (MRP1/ABCC1). Biochem. Biophys. Res. Commun. 365, 29-34
54. Létourneau, I. J., Slot, A. J., Deeley, R. G., and Cole, S. P. C. (2007) Mutational analysis of a highly conserved proline residue in MRP1, MRP2 and MRP3 reveals a partially conserved function. Drug Metab. Dispos. 35, 1372-1379
55. Iram, S. H., and Cole, S. P. C. (2011) Expression and function of human MRP1 (ABCC1) is dependent on amino acids in cytoplasmic loop 5 and its interface with nucleotide binding domain 2. J. Biol. Chem. 286, 7202-7213
56. 535 in cytoplasmic loop 5 cause differential misfolding in multiple domains of the multidrug and organic anion transporter MRP1 (ABCC1). J. Biol. Chem. 287, 7543-7555
57. Conseil, G., Rothnie, A. J., Deeley R. G., and Cole, S. P. C. (2009) Multiple roles of charged amino acids in cytoplasmic loop 7 for expression and function of the multidrug and organic anion transporter MRP1 (ABCC1). Mol. Pharmacol. 75, 397-406
58. Conseil, G., Deeley R. G., and Cole, S. P. C. (2006) Functional importance of three basic residues clustered at the cytosolic interface of transmembrane helix 15 in the multidrug and organic anion transporter MRP1 (ABCC1). J. Biol. Chem. 281, 43-50
59. Ishikawa, T. (1992) The ATP-dependent glutathione S-conjugate export pump. Trends Biochem. Sci. 17, 463-468
60. Jones, D. C., Duvauchelle, C., Ikegami, A., Olsen, C. M., Lau, S. S., de la Torre, R., and Monks, T. J. (2005) Serotonergic neurotoxic metabolites of ecstasy identified in rat brain. J. Pharmacol. Exp. Ther. 313, 422-431
61. Slot, A. J., Wise, D. D., Deeley, R. G., Monks, T. J., and Cole, S. P. C. (2008) Modulation of human MRP1 (ABCC1) and MRP2 (ABCC2) transport by endogenous and exogenous glutathione-conjugated catechol metabolites. Drug Metab. Dispos. 36, 552-560
62. 4 and structurally related conjugates. J. Biol. Chem. 269, 27807-27810
63. 4 and chemotherapeutic agents in membrane vesicles: demonstration of glutathione-dependent vincristine transport. J. Biol. Chem. 271, 9675-9682
64. Qian, Y. M., Song, W. C., Cui, H., Cole, S. P. C., and Deeley, R. G. (2001) Glutathione stimulates sulfated estrogen transport by multidrug resistance protein 1. J. Biol. Chem. 276, 6404-6411
65. Zelcer, N., Reid, G., Wielinga, P., Kuil, A., van der Heijden, I., Schuetz, J. D., and Borst, P. (2003) Steroid and bile acid conjugates are substrates of human multidrug-resistance protein (MRP) 4 (ATP-binding cassette C4). Biochem. J. 371, 361-367
66. Sakamoto, H., Hara, H., Hirano, K., and Adachi, T. (1999) Enhancement of glucuronosyl etoposide transport by glutathione in multidrug resistance-associated protein-overexpressing cells. Cancer Lett. 135, 113-119
67. Leslie, E. M., Ito, K., Upadhyaya, P., Hecht, S. S., Deeley, R. G., and Cole, S. P. C. (2001) Transport of the β-O-glucuronide conjugate of the tobac-co- specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by the multidrug resistance protein 1 (MRP1/ABCC1): requirement for glutathione or a non-sulfur-containing analog. J. Biol. Chem. 276, 27846-27854
68. Jedlitschky, G., Leier, I., Buchholz, U., Barnouin, K., Kurz, G., and Keppler, D. (1996) Transport of glutathione, glucuronate, and sulphate conjugates by the MRP gene-encoded conjugate export pump. Cancer Res. 56, 988-994
69. Newcomer, M. E., and Gilbert, N. C. (2010) Location, location, location: Compartmentalization of early events in leukotriene biosynthesis. J. Biol. Chem. 285, 25109-25114
70. Montuschi, P., and Peters-Golden, M. L. (2010) Leukotriene modifiers for asthma treatment. Clin. Exp. Allergy 40, 1732-1741
71. Budulac, S. E., Postma, D. S., Hiemstra, P. S., Kunz, L. I., Siedlinski, M., Smit, H. A., Vonk, J. M., Rutgers, B., Timens, W., Boezen, H. M., and Groningen Leiden Universities Corticosteroids in Obstructive Lung Disease (GLUCOLD) Study Group (2010) Multidrug resistance-associated protein-1 (MRP1) genetic variants, MRP1 protein levels and severity of COPD. Respir. Res. 11, 60
72. Lima, J. J., Blake, K. V., Tantisira, K. G., and Weiss, S. T. (2009) Pharmacogenetics of asthma. Curr. Opin. Pulm. Med. 15, 57-62
73. Evers, R., Cnubben, N. H., Wijnholds, J., van Deemter, L., van Bladeren, P. J., and Borst, P. (1997) Transport of glutathione prostaglandin A conjugates by the multidrug resistance protein 1. FEBS Lett. 419, 112-116
74. 2 in MCF7 breast cancer cells. Biochemistry 42, 5429-5437
75. 2. Liver Int. 26, 362-368
76. Lin, Z. P., Zhu, Y. L., Johnson, D. R., Rice, K. P., Nottoli, T., Hains, B. C., McGrath, J., Waxman, S. G., and Sartorelli, A. C. (2008) Disruption of cAMP and prostaglandin E2 transport by multidrug resistance protein 4 deficiency alters cAMP-mediated signalling and nociceptive response. Mol. Pharmacol. 73, 243-251
77. Dalleau, S., Baradat, M., Guéraud, F., and Huc, L. (2013) Cell death and diseases related to oxidative stress: 4-hydroxynonenal (HNE) in the balance. Cell Death Differ. 20, 1615-1630
78. Renes, J., de Vries, E. E., Hooiveld, G. J., Krikken, I., Jansen, P. L., and Müller, M. (2000) Multidrug resistance protein MRP1 protects against the toxicity of the major lipid peroxidation product 4-hydroxynonenal. Biochem. J. 350, 555-561
79. Frohnert, B. I., and Bernlohr, D. A. (2014) Glutathionylated products of lipid peroxidation: A novel mechanism of adipocyte to macrophage signaling. Adipocyte 3, 224-229
80. Yamashita, A., Oka, S., Tanikawa, T., Hayashi, Y., Nemoto-Sasaki, Y., and Sugiura, T. (2013) The actions and metabolism of lysophophatidylinositol, an endogenous agonist for GPR55. Prostaglandins Other Lipid Mediat. 107, 103-116
81. Piñeiro, R., and Falasca, M. (2012) Lysophosphatidylinositol signalling: new wine from an old bottle. Biochim. Biophys. Acta 1821, 694-705
82. Maceyka, M., Harikumar, K. B., Milstien, S., and Spiegel, S. (2012) Sphin-gosine- 1-phosphate signalling and its role in disease. Trends Cell Biol. 22, 50-60
83. Mitra, P., Oskeritzian, C. A., Payne, S. G., Beaven, M. A., Milstien, S., and Spiegel, S. (2006) Role of ABCC1 in export of sphingosine-1-phosphate from mast cells. Proc. Natl. Acad. Sci. U.S.A. 103, 16394-16399
84. Tanfin, Z., Serrano-Sanchez, M., and Leiber, D. (2011) ATP-binding cassette ABCC1 is involved in the release of sphingosine 1-phosphate from rat uterine leiomyoma ELT3 cells and late pregnant rat myometrium. Cell Signal. 23, 1997-2004
85. Ito, S., Iwaki, S., Koike, K., Yuda, Y., Nagasaki, A., Ohkawa, R., Yatomi, Y., Furumoto, T., Tsutsui, H., Sobel, B. E., and Fujii, S. (2013) Increased plasma sphingosine-1-phosphate in obese individuals and its capacity to increase the expression of plasminogen activator inhibitor-1 in adipocytes. Coron. Artery Dis. 24, 642-650
86. Cartwright, T. A., Campos, C. R., Cannon, R. E., and Miller, D. S. (2013) Mrp1 is essential for sphingolipid signaling to P-glycoprotein in mouse blood-brain and blood-spinal cord barriers. J. Cereb. Blood Flow Metab. 33, 381-388
87. Piñeiro, R., Maffucci, T., and Falasca, M. (2011) The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation. Oncogene 30, 142-152
88. Liu, B., Song, S., Jones, P. M., and Persaud, S. J. (2014) GPR55: From orphan to metabolic regulator? Pharmacol. Ther. 10.1016/j.pharmthera. 2014.06.007
89. Sylantyev, S., Jensen, T. P., Ross, R. A., and Rusakov, D. A. (2013) Canna-binoid- and lysophosphatidylinositol-sensitive receptor GPR55 boosts neurotransmitter release at central synapses. Proc. Natl. Acad. Sci. U.S.A. 110, 5193-5198
90. Borst, P., de Wolf, C., and van de Wetering, K. (2007) Multidrug resis-tance- associated proteins 3, 4, and 5. Pflugers Arch. 453, 661-673
91. Cheung, L., Flemming, C. L., Watt, F., Masada, N., Yu, D. M. T., Huynh, T., Conseil, G., Tivnan, A., Polinsky, A., Gudkov, A. V., Munoz, M. A., Vishvanath, A., Cooper, D. M., Henderson, M. J., Cole, S. P. C., Fletcher, J. I., Haber, M., and Norris, M. D. (2014) High-throughput screening identifies Ceefourin 1 and Ceefourin 2 as highly selective inhibitors of multidrug resistance protein 4 (MRP4). Biochem. Pharmacol. 91, 97-108
92. Zaman, G. J. R., Lankelma, J., van Tellingen, O., Beijnen, J., Dekker, H., Paulusma, C., Oude Elferink, R. P. J., Baas, F., and Borst, P. (1995) Role of glutathione in the export of compounds from cells by the multidrug-resistance- associated protein. Proc. Natl. Acad. Sci. U.S.A. 92, 7690-7694
93. Rappa, G., Lorico, A., Flavell, R. A., and Sartorelli, A. C. (1997) Evidence that the multidrug resistance protein (MRP) functions as a co-transporter of glutathione and natural product toxins. Cancer Res. 57, 5232-5237
94. Loe, D. W., Deeley, R. G., and Cole, S. P. C. (1998) Characterization of vincristine transport by the 190 kDa multidrug resistance protein, MRP: evidence for co-transport with reduced glutathione. Cancer Res. 58, 5130-5136
95. Rothnie, A., Conseil, G., Lau, A. Y. T., Deeley, R. G., and Cole, S. P. C. (2008) Mechanistic differences between GSH transport by MRP1 (ABCC1) andGSHmodulation of MRP1-mediated transport. Mol. Pharmacol. 74, 1630-1640
96. Lorico, A., Rappa, G., Finch, R. A., Yang, D., Flavell, R. A., and Sartorelli, A. C. (1997) Disruption of the murine MRP (multidrug resistance protein) gene leads to increased sensitivity to etoposide (VP-16) and increased levels of glutathione. Cancer Res. 57, 5238-5242
97. Leslie, E. M., Bowers, R. J., Deeley, R. G., and Cole, S. P. C. (2003) Structural requirements for functional interaction of glutathione tripeptide analogs with the human multidrug resistance protein 1 (MRP1). J. Pharmacol. Exp. Ther. 304, 643-653
98. Leslie, E. M., Deeley, R. G., and Cole, S. P. C. (2003) Bioflavonoid stimulation of glutathione transport by the 190-kDa multidrug resistance protein 1 (MRP1). Drug Metab. Dispos. 31, 11-15
99. Brechbuhl, H. M., Kachadourian, R., Min, E., Chan, D., and Day, B. J. (2012) Chrysin enhances doxorubicin-induced cytotoxicity in human lung epithelial cancer cell lines: the role of glutathione. Toxicol. Appl. Pharmacol. 258, 1-9
100. Bast, A., and Haenen, G. R. (2013) Ten misconceptions about antioxidants. Trends Pharmacol. Sci. 34, 430-436
101. Lok, H. C., Suryo Rahmanto, Y., Hawkins, C. L., Kalinowski, D. S., Morrow, C. S., Townsend, A. J., Ponka, P., and Richardson, D. R. (2012) Nitric oxide storage and transport in cells are mediated by glutathione S-transferase P1-1 and multidrug resistance protein 1 via dinitrosyl iron complexes. J. Biol. Chem. 287, 607-618
102. Leier, I., Jedlitschky, G., Buchholz, U., Center, M., Cole, S. P. C., Deeley, R. G., and Keppler, D. (1996) ATP-dependent glutathione disulfide transport mediated by the MRP gene-encoded conjugate export pump. Biochem. J. 314, 433-437
103. Minich, T., Riemer, J., Schulz, J. B., Wielinga, P., Wijnholds, J., and Dringen, R. (2006) The multidrug resistance protein 1 (Mrp1), but not Mrp5, mediates export of glutathione and glutathione disulfide from brain astrocytes. J. Neurochem. 97, 373-384